During the past decade, Breastlink Medical Group Inc conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 8 clinical trials were completed, i.e. on average, 800% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Breastlink Medical Group Inc" #1 sponsor was "National Cancer Institute (NCI)" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials sponsored, "Agendia" with 1 trials sponsored, "IceCure Medical Ltd." with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Breastlink Medical Group Inc" #1 collaborator was "NRG Oncology" with 2 trials as a collaborator, "NSABP Foundation Inc" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Cancer and Leukemia Group B" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Breastlink Medical Group Inc" are "Breast Cancer" (4 trials), "Stage IIA Breast Cancer AJCC v6 and v7" (3 trials), "Stage IIB Breast Cancer AJCC v6 and v7" (3 trials), "Stage IA Breast Cancer AJCC v7" (2 trials) and "Stage IB Breast Cancer AJCC v7" (2 trials). Many other conditions were trialed in "Breastlink Medical Group Inc" in a lesser frequency.

Most popular intervention types in "Breastlink Medical Group Inc" are "Drug" (7 trials), "Other" (5 trials), "Biological" (3 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (4 trials), "Cyclophosphamide" (2 trials), "Doxorubicin Hydrochloride" (2 trials), "Paclitaxel" (2 trials) and "Quality-of-Life Assessment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Breastlink Medical Group Inc" are 7 trials for "Female" genders and 4 trials for "All" genders.

Currently, there are NaN active trials in "Breastlink Medical Group Inc". undefined are not yet recruiting, undefined are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Breastlink Medical Group Inc, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Breastlink Medical Group Inc, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".